A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug dostarlimab with ...

The field of gynecological oncology has undergone significant transformations over the past few decades. Historically, the management of gynecological ...

The field of tumor immunology has highlighted the adeptness of tumor cells in evading the host's immune system. This insight has fueled interest in ...

Matulonis, MD, discusses preliminary efficacy and safety results for puxitatug samrotecan in patients with recurrent endometrial cancer ... had received prior immunotherapy,” Matulonis, chief ...

Immunotherapy drugs like dostarlimab have been used as a front-line treatment for some metastatic cancers, melanoma, and other cancer types. Dostarlimab was first approved for use in endometrial ...

It can also occur in younger women if they have a family history of ovarian, breast, endometrial or colorectal ... Treatments such as immunotherapy help the immune system detect and fight ovarian ...

and endometrial cancer" and can also be found in “cancers of the breast, prostate, bladder and thyroid.” The immunotherapy drug works by targeting cells with this mutation, as the ...

"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

These immunotherapy drugs effectively remove the “brakes” that cancer cells place on the ... The drug is already approved for treating endometrial cancers with the same genetic mutation.